Australia's largest stock trading and investment forum Australia's #1 stock forum

CAN

0.00%

6.2¢ cann group limited

Hey Gone, I may have my facts wrong and will need to look back...

First 11 Last

Share
Profile

Follow
Stickywithmicky

79 Posts.

34

31/12/21

22:41

Post #: 58593320
Share

Originally posted by Goneallin: ↑

“There will be significant costs involved with getting approval for an OTC S3 product with the biggest hurdle identifying and proving the product is medically beneficial in some way”

they already have these costs covered in the most recent cap raise.

”Happy to hear the thoughts of others as always, I for one continue to be glad they are minimising debt and continue to raise money in other ways”.

I disagree. I would rather they avoid further dilution with any more cap raise and extend the debt facility. My bet/hope is they will get a variation from nab for the debt facility to include working capital and extend it ‘x’ million
to address previous post around being able to increase revenue 70% year over year, I say why not? Cann currently cultivate 1.5 tonne, next CY they will be cultivating 14tonne. That’s a lot more than 70% increase in product...
like I have said previously, it all comes down to how much product they can move.

Expand

Hey Gone, I may have my facts wrong and will need to look back through the reports. I cannot remember CANN saying the costs of bringing the OTC S3 product to market were covered under the last cap raise, that raise was focused on the purchase and installation of the additional equipment at Mildura.

Can you please confirm? Thanks.

CAN Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply